Healthcare Transactions and Regulatory
The combination of our senior transactional counsel and our regulatory expertise makes us valued counsel in closing healthcare industry mergers, acquisitions, joint ventures, affiliations and other collaborations. Our practice is national in scope and involves all substantive aspects of healthcare transactions, including multistate regulatory approvals, legal risk assessments, tax structuring, antitrust analysis, and public company and going-private issues.
October 10, 2024
United States District Court in Florida Holds False Claims Act Qui Tam Provision Unconstitutional
July 8, 2024
Finally! FDA Issues Updated Draft Guidance on Diversity Action Plans Mandated by FDORA
January 17, 2023
Health Headlines – January 17, 2023
November 14, 2024
Rick Zall, who was named a Law360 2024 Healthcare MVP, discusses his biggest accomplishment of the year and more
October 21, 2024
Law360 Recognizes Stephen Orava, Tom Sprange KC and Richard Zall as 2024 MVPs
August 8, 2024
Leading product liability partner Andrew Calica joins the firm’s Product Liability and Mass Torts practice group in New York